SlideShare a Scribd company logo
MOBILE
BEST DATA PLANLorem Ipsum has two main statistical methodologies are used in data analysis which
summarizes data from a sample using indexes Tempor mediocrem imperdiet no usu,
tractatos salutatus ut est. Eu vel detraxit laboramus. Cu nam unum liber audiam.
Fertility Preservation inAddressing
Woman’s Biological Clock and
Decreasing fertility
Matheus Roque
ORIGEN – Centro de Medicina Reprodutiva -
BRAZIL
INSIGHT’17
Coimbatore
INDIA
28-29 Oct - 2017
WOMAN’S
Biological
Clock
FERTILITY
PRESERVATION
THE REAL LIFE …
41 years old
Single
AMH 0.9 ng/mL
41 years old (2014)
Single
AMH 0.9 ng/mL
June / 2014: 3 mature oocytes vitrified
September / 2014: + 3 oocytes vitrified
FERTILITY PRESERVATION
Should I freeze my eggs?
Fertility preservation in addressing women’s biological clock and decreasing fertility
41 years old
Single
With 6 vitrified oocytes – 2014
FERTILITY PRESERVATION
Should I freeze my eggs?
Fertility preservation in addressing women’s biological clock and decreasing fertility
41 years old
Single
With 6 vitrified oocytes – 2014
FERTILITY PRESERVATION ???
FERTILITY PRESERVATION
Should I freeze my eggs?
Fertility preservation in addressing women’s biological clock and decreasing fertility
OOCYTE CRYOPRESERVATION
Should I freeze my eggs?
41 years old
Single
With 6 vitrified oocytes - 2014
2017 – 44 years old
Amenorrhea; AMH 0.1
OOCYTE CRYOPRESERVATION
Should I freeze my eggs?
Fertility preservation in addressing women’s biological clock and decreasing fertility
41 years old
Single
2014 - With 6 vitrified oocytes
2017 – ICSI with sperm bank
TWINS
OOCYTE CRYOPRESERVATION
Should I freeze my eggs?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Presentation Goals
Why?
Is it effective?
Is it cost-effective?
When it should be done?
Are the women the same in different
countries?
OOCYTE CRYOPRESERVATION
Fertility preservation in addressing women’s biological clock and decreasing fertility
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fertility preservation in addressing women’s biological clock and decreasing fertility
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fertility preservation in addressing women’s biological clock and decreasing fertility
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fleming et al., Fertil Steril 2012
NGF
Non-growing follicles
Fertility preservation in addressing women’s biological clock and decreasing fertility
Faddy et al., Hum Reprod 1992; Cortvrint et al., Fertil Steril 2001
Birth
Optimal
Fertility
Decreased
Fertility
End of
Fertility
Irregular
menses
0 18 33 36 40 5127
Number of
follicles
1000
10000
100000
1000000
Pathological / Iatrogenic
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fertility preservation in addressing women’s biological clock and decreasing fertility
Pathological Iathrogenic
- Surgery
- Drugs – oncological / non-
oncological treatment
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fertility preservation in addressing women’s biological clock and decreasing fertility
70% 60% 50% 30% 15%
Ata et al., Reprod Biomed Online 2012
Even with a good ovarian reserve,
there is an important increase in
aneuploidy rates with advanced
maternal age
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fertility preservation in addressing women’s biological clock and decreasing fertility
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE
Fertility preservation in addressing women’s biological clock and decreasing fertility
Fertility preservation in addressing women’s biological clock and decreasing fertility
WHY OOCYTE CRYOPRESERVATION ?
OVARIAN RESERVE and OOCYTE QUALITY
Natural conception at a
relative early age
OOCYTE
CRYOPRESERVATION
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Trends of Elective Fertility Preservation
% Elective Fertility Preservation vs. Total number of oocyte vitrification
Presentation Goals
Why? Decrease in ovarian reserve and egg
quality
Is it effective?
OOCYTE CRYOPRESERVATION
Is it effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al, Fertil Steril 2015
OOCYTE CRYOPRESERVATION
Is it effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al, Fertil Steril 2015
0
10
20
30
40
50
60
70
80
90
100
6 months 6-12 months 12-18 months 18-24 months 24-36 months 36-48 months 48-60 months
39.7 37.9 38.1 38.4 35.6 36
100
%
IMPLANTATION RATE ACCORDING TO STORAGE TIME
Implantation Rate
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al, Fertil Steril 2015
OOCYTE CRYOPRESERVATION
Is it effective?
35
36
37
38
39
40
41
42
43
44
45
46
Implantation Rate OPR / ET OPR / cycle LBR / donation
cycle
39
45.3
39.9
39.1
%
Clinical outcomes cryopreserved oocytes - ovum donation
Clinical outcomes cryopreserved oocytes - ovum donation
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al, Fertil Steril 2015
OOCYTE CRYOPRESERVATION
Is it effective?
0
10
20
30
40
50
60
70
80
90
100
5 10 12 15 20 25 30 35 40 43
6.1
39.4
53.5
67.5
80.5
85.4 89.9
94.8 95.5 97.3
%
Cumulative live birth rate according to the number of oocytes
consumed
No. of consumed oocytes
Fertility preservation in addressing women’s biological clock and decreasing fertility
The arguments against allowing this
application of the technology are not
convincing
ESHERE Task Force, Hum Reprod 2012
OOCYTE CRYOPRESERVATION
Is it effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Oocyte vitrification and thawing should no
longer be considered experimental
ASRM, Fertil Steril 2013
OOCYTE CRYOPRESERVATION
Is it effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Is it effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Is it effective?
No. of oocytes according to women’s age
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al, Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Is it effective?
0
10
20
30
40
50
60
70
80
90
Survival Rate Embryo transfer
rate / patient
Implantation Rate Ongoing pregnancy
rate / patient
85.2 85.4
35.9
25
%
Clinical outcomes cryopreserved oocytes – elective cryopreservation
Clinical outcomes - Mean age at Fertility Preservation 37.2 years old
Fertility preservation in addressing women’s biological clock and decreasing fertility
Doyle et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Is it effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Doyle et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Is it effective?
0
10
20
30
40
50
60
70
80
Fertilization Rate IR CPR / Transfer LBR / transfer cycle
69.5
41.2
54.4
38.6
71.7
35.4
45.1
36
%
Clinical Outcomes – autologous ICSI cycles with vitrified vs fresh
oocytes
Vitrified Oocytes (n=128) - 34.9 years Fresh Oocytes (n=2963) - 35.5 years
Fertility preservation in addressing women’s biological clock and decreasing fertility
Doyle et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
Is it effective?
Predicted probability of having at least one, two, and three
children
Presentation Goals
Why? Decrease in ovarian reserve and egg
quality
Is it effective? YES
Is it cost-effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Hirshfeld-Cytron et al., Fertil Steril 2012
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Hirshfeld-Cytron et al., Fertil Steril 2012
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Oocyte cryopreservation is not cost-effective for
healthy women planning delayed childbearing
Fertility preservation in addressing women’s biological clock and decreasing fertility
Hirshfeld-Cytron et al., Fertil Steril 2012
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Oocyte cryopreservation is not cost-effective for
healthy women planning delayed childbearing
*oocyte cryopreservation at age 25
Fertility preservation in addressing women’s biological clock and decreasing fertility
Devineet al., Fertil Steril 2015
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Devine et al., Fertil Steril 2015
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Devine et al., Fertil Steril 2015
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Oocyte cryopreservation at age 25
Fertility preservation in addressing women’s biological clock and decreasing fertility
Van Loendersloot et al., Hum reprod 2012
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Fertility preservation in addressing women’s biological clock and decreasing fertility
OOCYTE CRYOPRESERVATION
Is it cost-effective?
Van Loendersloot et al., Hum reprod 2012
Presentation Goals
Why? Decrease in ovarian reserve and egg
quality
Is it effective? YES
Is it cost-effective? Controversial; probably
YES
When it should be done?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Mesen et al., Fertil Steril 2015
OOCYTE CRYOPRESERVATION
When it should be done?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Mesen et al., Fertil Steril 2015
OOCYTE CRYOPRESERVATION
When it should be done?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Mesen et al., Fertil Steril 2015
OOCYTE CRYOPRESERVATION
When it should be done?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Cobo et al., Fertil Steril 2016
OOCYTE CRYOPRESERVATION
When it should be done?
<= 35y
>= 36y
Presentation Goals
Why? Decrease in ovarian reserve and egg
quality
Is it effective? YES
Is it cost-effective? Controversial; probably
YES
When it should be done? < 35-37 years old
Presentation Goals
Why? Decrease in ovarian reserve and egg
quality
Is it effective? YES
Is it cost-effective? Controversial; probably
YES
When it should be done? < 35-37 years old
Are there differences in different ethinicity?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Iglesias et al., Fertil Steril 2014
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Iglesias et al., Fertil Steril 2014
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Iglesias et al., Fertil Steril 2014
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Iglesias et al., Fertil Steril 2014
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
Fertility preservation in addressing women’s biological clock and decreasing fertility
Iglesias et al., Fertil Steril 2014
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
Total gonadotropin (IU) 2,420  840 2,910  902 <.001
INDIAN WOMEN: 6-year advancement in ovarian aging
Sub-optimal response
Fertility preservation in addressing women’s biological clock and decreasing fertility
Maalouf et al., BJOG 2016
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
United Kingdom (UK) Database
2000 to 2010: 38,709 women
Live birth rate and the effect of ethnicity
Fertility preservation in addressing women’s biological clock and decreasing fertility
Maalouf et al., BJOG 2016
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
If true biologic differences exist, they may profoundly affect
patient counseling and the adaptation of COS protocols to
biologic age rather than chronologic age
Iglesias et al., 2014
Fertility preservation in addressing women’s biological clock and decreasing fertility
Maalouf et al., BJOG 2016
OOCYTE CRYOPRESERVATION
Are there differences in different ethinicity?
Presentation Goals
Why? Decrease in ovarian reserve and egg
quality
Is it effective? YES
Is it cost-effective? Controversial; probably
YES
When it should be done? < 35-37 years old
Are there differences in different ethinicity?
Probably YES
Fertility preservation in addressing women’s biological clock and decreasing fertility
Is this the perfect strategy to make sure a
woman will delivery a baby in the future ???
OOCYTE CRYOPRESEVATION
But so far, this is the BEST strategy to
increase the chances of delivering a baby
with own oocytes in the future
TAKE –HOME MESSAGES
OOCYTE CRYOPRESERVATION
Oocyte vitrification should not be considered as experimental
It is not the guarantee of future pregnancy, but can really
increase the chance
Adequate information / avoid raising false hopes
The final decision is not ours but the patient's
The women should be advised about Oocyte
Cryopreservation
Corpo Clínico:
Marcello Valle
Selmo Geber
Marcos Sampaio
Matheus Roque
Rodolfo Salvato
Alessandra Kostolias
Rafaela Batisti
Mauro Bellece
Monique Ubaldo
Ana Carolina Iacob
Rodrigo Abud
Nilson Lama
Françoise Padula
Thank you!
matheusroque@origen.com.br
pt.slideshare.net/MatheusRoque1
Laboratório:
Brunna Vaz
Lucas Nazareth
Ana Carolina Pontes
Thaiza
Psicologia:
Sheila Veloso
Enfermagem:
Karla Santiago
Adriana Janotti
Thais Bastos
Joana Paes
Marcelle
Nutrição:
Camilla Estima

More Related Content

What's hot

Revealing human embryos,ragaa mansour
Revealing human embryos,ragaa mansourRevealing human embryos,ragaa mansour
Revealing human embryos,ragaa mansour
Hesham Al-Inany
 
Adjuvant therapy
Adjuvant therapyAdjuvant therapy
Adjuvant therapy
Hesham Al-Inany
 
Adjuvant procedures in IVF
Adjuvant procedures in IVFAdjuvant procedures in IVF
Adjuvant procedures in IVF
Walid Ahmed
 
複製 Human embryo transfer11
複製  Human   embryo   transfer11複製  Human   embryo   transfer11
複製 Human embryo transfer11t7260678
 
Poor response in IVF : How to manage : 2018
Poor response in IVF : How to manage : 2018Poor response in IVF : How to manage : 2018
Poor response in IVF : How to manage : 2018
Hesham Al-Inany
 
4G ovarian stimulation
4G ovarian stimulation 4G ovarian stimulation
4G ovarian stimulation
Hesham Al-Inany
 
Elonva: A new patient friendly approach in ART
Elonva: A new patient friendly approach in ARTElonva: A new patient friendly approach in ART
Elonva: A new patient friendly approach in ARTYuzko Olexandr
 
Day 3 vs day 5 embryo transfer
Day 3 vs day 5 embryo transferDay 3 vs day 5 embryo transfer
Day 3 vs day 5 embryo transfer
Hesham Al-Inany
 
O.i 2021
O.i 2021O.i 2021
O.i 2021
Hesham Al-Inany
 
Improving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individualsImproving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individuals
Sandro Esteves
 
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
Free Information Session 5th September 2012:  Recent Breakthroughs in IVFFree Information Session 5th September 2012:  Recent Breakthroughs in IVF
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
Fertility SA
 
Optimize oocyte yield to maximize live birth in ART
Optimize oocyte yield to maximize live birth in ARTOptimize oocyte yield to maximize live birth in ART
Optimize oocyte yield to maximize live birth in ART
Sandro Esteves
 
Ivf adj th kasum
Ivf adj th kasumIvf adj th kasum
Ivf adj th kasumt7260678
 
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Sandro Esteves
 
Ohss
OhssOhss
GnRH costeffectiveness
GnRH costeffectivenessGnRH costeffectiveness
GnRH costeffectiveness
Hesham Al-Inany
 
Reproductive Immunology
Reproductive ImmunologyReproductive Immunology
Reproductive Immunology
Sujoy Dasgupta
 
ovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 update
Hesham Al-Inany
 
Progesterone for luteal phase support in IVF cycles
 Progesterone for luteal phase support in IVF  cycles Progesterone for luteal phase support in IVF  cycles
Progesterone for luteal phase support in IVF cycles
Hesham Al-Inany
 

What's hot (20)

Revealing human embryos,ragaa mansour
Revealing human embryos,ragaa mansourRevealing human embryos,ragaa mansour
Revealing human embryos,ragaa mansour
 
Adjuvant therapy
Adjuvant therapyAdjuvant therapy
Adjuvant therapy
 
Adjuvant procedures in IVF
Adjuvant procedures in IVFAdjuvant procedures in IVF
Adjuvant procedures in IVF
 
複製 Human embryo transfer11
複製  Human   embryo   transfer11複製  Human   embryo   transfer11
複製 Human embryo transfer11
 
Poor response in IVF : How to manage : 2018
Poor response in IVF : How to manage : 2018Poor response in IVF : How to manage : 2018
Poor response in IVF : How to manage : 2018
 
4G ovarian stimulation
4G ovarian stimulation 4G ovarian stimulation
4G ovarian stimulation
 
Elonva: A new patient friendly approach in ART
Elonva: A new patient friendly approach in ARTElonva: A new patient friendly approach in ART
Elonva: A new patient friendly approach in ART
 
Day 3 vs day 5 embryo transfer
Day 3 vs day 5 embryo transferDay 3 vs day 5 embryo transfer
Day 3 vs day 5 embryo transfer
 
O.i 2021
O.i 2021O.i 2021
O.i 2021
 
Improving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individualsImproving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individuals
 
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
Free Information Session 5th September 2012:  Recent Breakthroughs in IVFFree Information Session 5th September 2012:  Recent Breakthroughs in IVF
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
 
Optimize oocyte yield to maximize live birth in ART
Optimize oocyte yield to maximize live birth in ARTOptimize oocyte yield to maximize live birth in ART
Optimize oocyte yield to maximize live birth in ART
 
Ivf adj th kasum
Ivf adj th kasumIvf adj th kasum
Ivf adj th kasum
 
High responders
High respondersHigh responders
High responders
 
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
 
Ohss
OhssOhss
Ohss
 
GnRH costeffectiveness
GnRH costeffectivenessGnRH costeffectiveness
GnRH costeffectiveness
 
Reproductive Immunology
Reproductive ImmunologyReproductive Immunology
Reproductive Immunology
 
ovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 update
 
Progesterone for luteal phase support in IVF cycles
 Progesterone for luteal phase support in IVF  cycles Progesterone for luteal phase support in IVF  cycles
Progesterone for luteal phase support in IVF cycles
 

Similar to Fertility preservation in addressing women's biological clock and decreasing fertility

HOW TO PREPARE A PATIET FOR IVF.pptx
HOW TO PREPARE A PATIET FOR IVF.pptxHOW TO PREPARE A PATIET FOR IVF.pptx
HOW TO PREPARE A PATIET FOR IVF.pptx
alwakilm
 
Dr. lee weng soon james
Dr. lee weng soon jamesDr. lee weng soon james
Dr. lee weng soon james
chanchal Sharma
 
000 bio zhena fiv presentation 031010 public
000 bio zhena fiv presentation   031010 public000 bio zhena fiv presentation   031010 public
000 bio zhena fiv presentation 031010 public
Vaclav Kirsner, PhD
 
IVF PREGNANCY-IS IT DIFFERENT
IVF PREGNANCY-IS IT DIFFERENTIVF PREGNANCY-IS IT DIFFERENT
IVF PREGNANCY-IS IT DIFFERENT
Dr. Sunita Chandra
 
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Lifecare Centre
 
Presentation on Optimizing IUI Outcome by Dr. Laxmi Shrikhande
Presentation on Optimizing IUI Outcome by Dr. Laxmi ShrikhandePresentation on Optimizing IUI Outcome by Dr. Laxmi Shrikhande
Presentation on Optimizing IUI Outcome by Dr. Laxmi Shrikhande
Dr.Laxmi Agrawal Shrikhande
 
Endometrial scratch final converted
Endometrial scratch final convertedEndometrial scratch final converted
Endometrial scratch final converted
Dr. Abha Majumdar
 
Role of Atosiban In ART 2018 Dr Jyoti Agarwal
Role of Atosiban In ART 2018 Dr Jyoti Agarwal Role of Atosiban In ART 2018 Dr Jyoti Agarwal
Role of Atosiban In ART 2018 Dr Jyoti Agarwal
Lifecare Centre
 
Challenging scenarios in infertility
Challenging scenarios in infertilityChallenging scenarios in infertility
Challenging scenarios in infertility
NARENDRA MALHOTRA
 
Role of Atosiban In ART ,Dr Jyoti Agarwal, Dr. Sharda Jain
Role of Atosiban In ART,Dr Jyoti Agarwal, Dr. Sharda Jain Role of Atosiban In ART,Dr Jyoti Agarwal, Dr. Sharda Jain
Role of Atosiban In ART ,Dr Jyoti Agarwal, Dr. Sharda Jain
Lifecare Centre
 
Dr. lien lian sze
Dr. lien lian szeDr. lien lian sze
Dr. lien lian sze
chanchal Sharma
 
DR SUNITA CHANDRA, LUCKNOW
DR SUNITA CHANDRA, LUCKNOWDR SUNITA CHANDRA, LUCKNOW
DR SUNITA CHANDRA, LUCKNOW
Dr. Sunita Chandra
 
Pre art evaluation and preparation,For Best Results both Husband & wife , lif...
Pre art evaluation and preparation,For Best Results both Husband & wife , lif...Pre art evaluation and preparation,For Best Results both Husband & wife , lif...
Pre art evaluation and preparation,For Best Results both Husband & wife , lif...
Lifecare Centre
 
Fertility Options: IVF Overview
Fertility Options: IVF OverviewFertility Options: IVF Overview
Fertility Options: IVF Overview
Mark Perloe
 
Micronised progesterone in preterm labour
Micronised progesterone in preterm labourMicronised progesterone in preterm labour
Micronised progesterone in preterm labour
Dr Meenakshi Sharma
 
MICROBIOME IN ART & Need of Probiotics Dr Sharda Jain Dr Jyoti Agarwal
MICROBIOME IN ART& Need of Probiotics  Dr Sharda Jain Dr Jyoti Agarwal MICROBIOME IN ART& Need of Probiotics  Dr Sharda Jain Dr Jyoti Agarwal
MICROBIOME IN ART & Need of Probiotics Dr Sharda Jain Dr Jyoti Agarwal
Lifecare Centre
 
Dr. indranil saha
Dr. indranil saha Dr. indranil saha
Dr. indranil saha
Harmeet Ela
 
Dr. indranil saha
Dr. indranil saha Dr. indranil saha
Dr. indranil saha
Harmeet Ela
 
AMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptxAMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptx
Dr.Laxmi Agrawal Shrikhande
 

Similar to Fertility preservation in addressing women's biological clock and decreasing fertility (20)

Techniques Of Art
Techniques Of ArtTechniques Of Art
Techniques Of Art
 
HOW TO PREPARE A PATIET FOR IVF.pptx
HOW TO PREPARE A PATIET FOR IVF.pptxHOW TO PREPARE A PATIET FOR IVF.pptx
HOW TO PREPARE A PATIET FOR IVF.pptx
 
Dr. lee weng soon james
Dr. lee weng soon jamesDr. lee weng soon james
Dr. lee weng soon james
 
000 bio zhena fiv presentation 031010 public
000 bio zhena fiv presentation   031010 public000 bio zhena fiv presentation   031010 public
000 bio zhena fiv presentation 031010 public
 
IVF PREGNANCY-IS IT DIFFERENT
IVF PREGNANCY-IS IT DIFFERENTIVF PREGNANCY-IS IT DIFFERENT
IVF PREGNANCY-IS IT DIFFERENT
 
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
Female infertility 2017 : CRITICAL REVIEW OF Assessment & treatment in India ...
 
Presentation on Optimizing IUI Outcome by Dr. Laxmi Shrikhande
Presentation on Optimizing IUI Outcome by Dr. Laxmi ShrikhandePresentation on Optimizing IUI Outcome by Dr. Laxmi Shrikhande
Presentation on Optimizing IUI Outcome by Dr. Laxmi Shrikhande
 
Endometrial scratch final converted
Endometrial scratch final convertedEndometrial scratch final converted
Endometrial scratch final converted
 
Role of Atosiban In ART 2018 Dr Jyoti Agarwal
Role of Atosiban In ART 2018 Dr Jyoti Agarwal Role of Atosiban In ART 2018 Dr Jyoti Agarwal
Role of Atosiban In ART 2018 Dr Jyoti Agarwal
 
Challenging scenarios in infertility
Challenging scenarios in infertilityChallenging scenarios in infertility
Challenging scenarios in infertility
 
Role of Atosiban In ART ,Dr Jyoti Agarwal, Dr. Sharda Jain
Role of Atosiban In ART,Dr Jyoti Agarwal, Dr. Sharda Jain Role of Atosiban In ART,Dr Jyoti Agarwal, Dr. Sharda Jain
Role of Atosiban In ART ,Dr Jyoti Agarwal, Dr. Sharda Jain
 
Dr. lien lian sze
Dr. lien lian szeDr. lien lian sze
Dr. lien lian sze
 
DR SUNITA CHANDRA, LUCKNOW
DR SUNITA CHANDRA, LUCKNOWDR SUNITA CHANDRA, LUCKNOW
DR SUNITA CHANDRA, LUCKNOW
 
Pre art evaluation and preparation,For Best Results both Husband & wife , lif...
Pre art evaluation and preparation,For Best Results both Husband & wife , lif...Pre art evaluation and preparation,For Best Results both Husband & wife , lif...
Pre art evaluation and preparation,For Best Results both Husband & wife , lif...
 
Fertility Options: IVF Overview
Fertility Options: IVF OverviewFertility Options: IVF Overview
Fertility Options: IVF Overview
 
Micronised progesterone in preterm labour
Micronised progesterone in preterm labourMicronised progesterone in preterm labour
Micronised progesterone in preterm labour
 
MICROBIOME IN ART & Need of Probiotics Dr Sharda Jain Dr Jyoti Agarwal
MICROBIOME IN ART& Need of Probiotics  Dr Sharda Jain Dr Jyoti Agarwal MICROBIOME IN ART& Need of Probiotics  Dr Sharda Jain Dr Jyoti Agarwal
MICROBIOME IN ART & Need of Probiotics Dr Sharda Jain Dr Jyoti Agarwal
 
Dr. indranil saha
Dr. indranil saha Dr. indranil saha
Dr. indranil saha
 
Dr. indranil saha
Dr. indranil saha Dr. indranil saha
Dr. indranil saha
 
AMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptxAMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptx
 

More from Matheus Roque

Infertilidade Masculina ARTE Academy
Infertilidade Masculina ARTE AcademyInfertilidade Masculina ARTE Academy
Infertilidade Masculina ARTE Academy
Matheus Roque
 
Congelamento Social: Promessa ou Panacéia?
Congelamento Social: Promessa ou Panacéia?Congelamento Social: Promessa ou Panacéia?
Congelamento Social: Promessa ou Panacéia?
Matheus Roque
 
Estímulo ovariano e endométrio
Estímulo ovariano e endométrioEstímulo ovariano e endométrio
Estímulo ovariano e endométrio
Matheus Roque
 
Avaliação feminina - o que devemos levar em consideração
Avaliação feminina - o que devemos levar em consideração Avaliação feminina - o que devemos levar em consideração
Avaliação feminina - o que devemos levar em consideração
Matheus Roque
 
Quando indicar ou não as Técnicas de Reprodução Assistida
Quando indicar ou não as Técnicas de Reprodução AssistidaQuando indicar ou não as Técnicas de Reprodução Assistida
Quando indicar ou não as Técnicas de Reprodução Assistida
Matheus Roque
 
Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...
Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...
Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...
Matheus Roque
 

More from Matheus Roque (6)

Infertilidade Masculina ARTE Academy
Infertilidade Masculina ARTE AcademyInfertilidade Masculina ARTE Academy
Infertilidade Masculina ARTE Academy
 
Congelamento Social: Promessa ou Panacéia?
Congelamento Social: Promessa ou Panacéia?Congelamento Social: Promessa ou Panacéia?
Congelamento Social: Promessa ou Panacéia?
 
Estímulo ovariano e endométrio
Estímulo ovariano e endométrioEstímulo ovariano e endométrio
Estímulo ovariano e endométrio
 
Avaliação feminina - o que devemos levar em consideração
Avaliação feminina - o que devemos levar em consideração Avaliação feminina - o que devemos levar em consideração
Avaliação feminina - o que devemos levar em consideração
 
Quando indicar ou não as Técnicas de Reprodução Assistida
Quando indicar ou não as Técnicas de Reprodução AssistidaQuando indicar ou não as Técnicas de Reprodução Assistida
Quando indicar ou não as Técnicas de Reprodução Assistida
 
Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...
Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...
Papel do LH na indução ovularia: quando e como utilizar. Diretrizes do estudo...
 

Recently uploaded

Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
ranishasharma67
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 

Recently uploaded (20)

Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 

Fertility preservation in addressing women's biological clock and decreasing fertility

  • 1. MOBILE BEST DATA PLANLorem Ipsum has two main statistical methodologies are used in data analysis which summarizes data from a sample using indexes Tempor mediocrem imperdiet no usu, tractatos salutatus ut est. Eu vel detraxit laboramus. Cu nam unum liber audiam. Fertility Preservation inAddressing Woman’s Biological Clock and Decreasing fertility Matheus Roque ORIGEN – Centro de Medicina Reprodutiva - BRAZIL INSIGHT’17 Coimbatore INDIA 28-29 Oct - 2017
  • 5. 41 years old (2014) Single AMH 0.9 ng/mL June / 2014: 3 mature oocytes vitrified September / 2014: + 3 oocytes vitrified FERTILITY PRESERVATION Should I freeze my eggs? Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 6. 41 years old Single With 6 vitrified oocytes – 2014 FERTILITY PRESERVATION Should I freeze my eggs? Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 7. 41 years old Single With 6 vitrified oocytes – 2014 FERTILITY PRESERVATION ??? FERTILITY PRESERVATION Should I freeze my eggs? Fertility preservation in addressing women’s biological clock and decreasing fertility OOCYTE CRYOPRESERVATION Should I freeze my eggs?
  • 8. 41 years old Single With 6 vitrified oocytes - 2014 2017 – 44 years old Amenorrhea; AMH 0.1 OOCYTE CRYOPRESERVATION Should I freeze my eggs? Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 9. 41 years old Single 2014 - With 6 vitrified oocytes 2017 – ICSI with sperm bank TWINS OOCYTE CRYOPRESERVATION Should I freeze my eggs? Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 10. Presentation Goals Why? Is it effective? Is it cost-effective? When it should be done? Are the women the same in different countries?
  • 11. OOCYTE CRYOPRESERVATION Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 12. WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 13. WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 14. WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fleming et al., Fertil Steril 2012 NGF Non-growing follicles Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 15. Faddy et al., Hum Reprod 1992; Cortvrint et al., Fertil Steril 2001 Birth Optimal Fertility Decreased Fertility End of Fertility Irregular menses 0 18 33 36 40 5127 Number of follicles 1000 10000 100000 1000000 Pathological / Iatrogenic WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 16. Pathological Iathrogenic - Surgery - Drugs – oncological / non- oncological treatment WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 17. 70% 60% 50% 30% 15% Ata et al., Reprod Biomed Online 2012 Even with a good ovarian reserve, there is an important increase in aneuploidy rates with advanced maternal age WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 18. WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE Fertility preservation in addressing women’s biological clock and decreasing fertility
  • 19. Fertility preservation in addressing women’s biological clock and decreasing fertility WHY OOCYTE CRYOPRESERVATION ? OVARIAN RESERVE and OOCYTE QUALITY Natural conception at a relative early age OOCYTE CRYOPRESERVATION
  • 20. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION Trends of Elective Fertility Preservation % Elective Fertility Preservation vs. Total number of oocyte vitrification
  • 21. Presentation Goals Why? Decrease in ovarian reserve and egg quality Is it effective?
  • 22. OOCYTE CRYOPRESERVATION Is it effective? Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al, Fertil Steril 2015
  • 23. OOCYTE CRYOPRESERVATION Is it effective? Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al, Fertil Steril 2015 0 10 20 30 40 50 60 70 80 90 100 6 months 6-12 months 12-18 months 18-24 months 24-36 months 36-48 months 48-60 months 39.7 37.9 38.1 38.4 35.6 36 100 % IMPLANTATION RATE ACCORDING TO STORAGE TIME Implantation Rate
  • 24. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al, Fertil Steril 2015 OOCYTE CRYOPRESERVATION Is it effective? 35 36 37 38 39 40 41 42 43 44 45 46 Implantation Rate OPR / ET OPR / cycle LBR / donation cycle 39 45.3 39.9 39.1 % Clinical outcomes cryopreserved oocytes - ovum donation Clinical outcomes cryopreserved oocytes - ovum donation
  • 25. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al, Fertil Steril 2015 OOCYTE CRYOPRESERVATION Is it effective? 0 10 20 30 40 50 60 70 80 90 100 5 10 12 15 20 25 30 35 40 43 6.1 39.4 53.5 67.5 80.5 85.4 89.9 94.8 95.5 97.3 % Cumulative live birth rate according to the number of oocytes consumed No. of consumed oocytes
  • 26. Fertility preservation in addressing women’s biological clock and decreasing fertility The arguments against allowing this application of the technology are not convincing ESHERE Task Force, Hum Reprod 2012 OOCYTE CRYOPRESERVATION Is it effective?
  • 27. Fertility preservation in addressing women’s biological clock and decreasing fertility Oocyte vitrification and thawing should no longer be considered experimental ASRM, Fertil Steril 2013 OOCYTE CRYOPRESERVATION Is it effective?
  • 28. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION Is it effective?
  • 29. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION Is it effective? No. of oocytes according to women’s age
  • 30. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al, Fertil Steril 2016 OOCYTE CRYOPRESERVATION Is it effective? 0 10 20 30 40 50 60 70 80 90 Survival Rate Embryo transfer rate / patient Implantation Rate Ongoing pregnancy rate / patient 85.2 85.4 35.9 25 % Clinical outcomes cryopreserved oocytes – elective cryopreservation Clinical outcomes - Mean age at Fertility Preservation 37.2 years old
  • 31. Fertility preservation in addressing women’s biological clock and decreasing fertility Doyle et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION Is it effective?
  • 32. Fertility preservation in addressing women’s biological clock and decreasing fertility Doyle et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION Is it effective? 0 10 20 30 40 50 60 70 80 Fertilization Rate IR CPR / Transfer LBR / transfer cycle 69.5 41.2 54.4 38.6 71.7 35.4 45.1 36 % Clinical Outcomes – autologous ICSI cycles with vitrified vs fresh oocytes Vitrified Oocytes (n=128) - 34.9 years Fresh Oocytes (n=2963) - 35.5 years
  • 33. Fertility preservation in addressing women’s biological clock and decreasing fertility Doyle et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION Is it effective? Predicted probability of having at least one, two, and three children
  • 34. Presentation Goals Why? Decrease in ovarian reserve and egg quality Is it effective? YES Is it cost-effective?
  • 35. Fertility preservation in addressing women’s biological clock and decreasing fertility Hirshfeld-Cytron et al., Fertil Steril 2012 OOCYTE CRYOPRESERVATION Is it cost-effective?
  • 36. Fertility preservation in addressing women’s biological clock and decreasing fertility Hirshfeld-Cytron et al., Fertil Steril 2012 OOCYTE CRYOPRESERVATION Is it cost-effective? Oocyte cryopreservation is not cost-effective for healthy women planning delayed childbearing
  • 37. Fertility preservation in addressing women’s biological clock and decreasing fertility Hirshfeld-Cytron et al., Fertil Steril 2012 OOCYTE CRYOPRESERVATION Is it cost-effective? Oocyte cryopreservation is not cost-effective for healthy women planning delayed childbearing *oocyte cryopreservation at age 25
  • 38. Fertility preservation in addressing women’s biological clock and decreasing fertility Devineet al., Fertil Steril 2015 OOCYTE CRYOPRESERVATION Is it cost-effective?
  • 39. Fertility preservation in addressing women’s biological clock and decreasing fertility Devine et al., Fertil Steril 2015 OOCYTE CRYOPRESERVATION Is it cost-effective?
  • 40. Fertility preservation in addressing women’s biological clock and decreasing fertility Devine et al., Fertil Steril 2015 OOCYTE CRYOPRESERVATION Is it cost-effective? Oocyte cryopreservation at age 25
  • 41. Fertility preservation in addressing women’s biological clock and decreasing fertility Van Loendersloot et al., Hum reprod 2012 OOCYTE CRYOPRESERVATION Is it cost-effective?
  • 42. Fertility preservation in addressing women’s biological clock and decreasing fertility OOCYTE CRYOPRESERVATION Is it cost-effective? Van Loendersloot et al., Hum reprod 2012
  • 43. Presentation Goals Why? Decrease in ovarian reserve and egg quality Is it effective? YES Is it cost-effective? Controversial; probably YES When it should be done?
  • 44. Fertility preservation in addressing women’s biological clock and decreasing fertility Mesen et al., Fertil Steril 2015 OOCYTE CRYOPRESERVATION When it should be done?
  • 45. Fertility preservation in addressing women’s biological clock and decreasing fertility Mesen et al., Fertil Steril 2015 OOCYTE CRYOPRESERVATION When it should be done?
  • 46. Fertility preservation in addressing women’s biological clock and decreasing fertility Mesen et al., Fertil Steril 2015 OOCYTE CRYOPRESERVATION When it should be done?
  • 47. Fertility preservation in addressing women’s biological clock and decreasing fertility Cobo et al., Fertil Steril 2016 OOCYTE CRYOPRESERVATION When it should be done? <= 35y >= 36y
  • 48. Presentation Goals Why? Decrease in ovarian reserve and egg quality Is it effective? YES Is it cost-effective? Controversial; probably YES When it should be done? < 35-37 years old
  • 49. Presentation Goals Why? Decrease in ovarian reserve and egg quality Is it effective? YES Is it cost-effective? Controversial; probably YES When it should be done? < 35-37 years old Are there differences in different ethinicity?
  • 50. Fertility preservation in addressing women’s biological clock and decreasing fertility Iglesias et al., Fertil Steril 2014 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity?
  • 51. Fertility preservation in addressing women’s biological clock and decreasing fertility Iglesias et al., Fertil Steril 2014 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity?
  • 52. Fertility preservation in addressing women’s biological clock and decreasing fertility Iglesias et al., Fertil Steril 2014 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity?
  • 53. Fertility preservation in addressing women’s biological clock and decreasing fertility Iglesias et al., Fertil Steril 2014 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity?
  • 54. Fertility preservation in addressing women’s biological clock and decreasing fertility Iglesias et al., Fertil Steril 2014 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity? Total gonadotropin (IU) 2,420  840 2,910  902 <.001 INDIAN WOMEN: 6-year advancement in ovarian aging Sub-optimal response
  • 55. Fertility preservation in addressing women’s biological clock and decreasing fertility Maalouf et al., BJOG 2016 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity? United Kingdom (UK) Database 2000 to 2010: 38,709 women Live birth rate and the effect of ethnicity
  • 56. Fertility preservation in addressing women’s biological clock and decreasing fertility Maalouf et al., BJOG 2016 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity?
  • 57. If true biologic differences exist, they may profoundly affect patient counseling and the adaptation of COS protocols to biologic age rather than chronologic age Iglesias et al., 2014 Fertility preservation in addressing women’s biological clock and decreasing fertility Maalouf et al., BJOG 2016 OOCYTE CRYOPRESERVATION Are there differences in different ethinicity?
  • 58. Presentation Goals Why? Decrease in ovarian reserve and egg quality Is it effective? YES Is it cost-effective? Controversial; probably YES When it should be done? < 35-37 years old Are there differences in different ethinicity? Probably YES
  • 59. Fertility preservation in addressing women’s biological clock and decreasing fertility Is this the perfect strategy to make sure a woman will delivery a baby in the future ??? OOCYTE CRYOPRESEVATION But so far, this is the BEST strategy to increase the chances of delivering a baby with own oocytes in the future
  • 60. TAKE –HOME MESSAGES OOCYTE CRYOPRESERVATION Oocyte vitrification should not be considered as experimental It is not the guarantee of future pregnancy, but can really increase the chance Adequate information / avoid raising false hopes The final decision is not ours but the patient's The women should be advised about Oocyte Cryopreservation
  • 61. Corpo Clínico: Marcello Valle Selmo Geber Marcos Sampaio Matheus Roque Rodolfo Salvato Alessandra Kostolias Rafaela Batisti Mauro Bellece Monique Ubaldo Ana Carolina Iacob Rodrigo Abud Nilson Lama Françoise Padula Thank you! matheusroque@origen.com.br pt.slideshare.net/MatheusRoque1 Laboratório: Brunna Vaz Lucas Nazareth Ana Carolina Pontes Thaiza Psicologia: Sheila Veloso Enfermagem: Karla Santiago Adriana Janotti Thais Bastos Joana Paes Marcelle Nutrição: Camilla Estima